This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
giant-cell-arteritis
Giant Cell Arteritis
Giant cell arteritis (GCA) is the most common primary vasculitis in adults >50; granulomatous inflammation of temporal arteries and aortic branches; IL-6 and IL-1β drive pathogenesis. Tocilizumab (anti-IL-6R; GiACTA; FDA May 2017) is the first approved steroid-sparing therapy.
Entry Metadata
| Field | Value |
|---|---|
| ID | giant-cell-arteritis |
| Name | Giant Cell Arteritis |
| Status | draft |
| Last reviewed | 2026-06-07 |
| Atlas | 01-human |
| Scale | 07-system |